Gene · 962
Papers3,378
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
801 to 820 of 3,378
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Eosinophil-lymphocyte interactions in the tumor microenvironment and cancer immunotherapy. | Nat Immunol | 2022 | 36002647 | PubTator, text mining | PubMed |
| The RPL4P4 Pseudogene Is a Prognostic Biomarker and Is Associated with Immune Infiltration in Glioma. | Oxid Med Cell Longev | 2022 | 35993018 | PubTator, text mining | PubMed |
| Amino acid metabolism genes associated with immunotherapy responses and clinical prognosis of colorectal cancer. | Front Mol Biosci | 2022 | 35992263 | PubTator, text mining | PubMed |
| X-box Binding Protein 1 is a Potential Immunotherapy Target in Ovarian Cancer. | Front Genet | 2022 | 35991556 | PubTator, text mining | PubMed |
| Strong T-cell activation in response to COVID-19 vaccination in multiple sclerosis patients receiving B-cell depleting therapies. | Front Immunol | 2022 | 35990701 | PubTator, text mining | PubMed |
| NAPSB as a predictive marker for prognosis and therapy associated with an immuno-hot tumor microenvironment in hepatocellular carcinoma. | BMC Gastroenterol | 2022 | 35987606 | PubTator, text mining | PubMed |
| Spatially resolved deconvolution of the fibrotic niche in lung fibrosis. | Cell Rep | 2022 | 35977489 | PubTator, text mining | PubMed |
| Characterisation of Disease Patterns of Dermatomyositis with Different Initial Manifestations. | Int J Gen Med | 2022 | 35971527 | PubTator, text mining | PubMed |
| The DCMU Herbicide Shapes T-cell Functions By Modulating Micro-RNA Expression Profiles. | Front Immunol | 2022 | 35967413 | PubTator, text mining | PubMed |
| In silico development and validation of a novel glucose and lipid metabolism-related gene signature in gastric cancer. | Transl Cancer Res | 2022 | 35966316 | PubTator, text mining | PubMed |
| Analysis of melanoma tumor antigens and immune subtypes for the development of mRNA vaccine. | Invest New Drugs | 2022 | 35962880 | PubTator, text mining | PubMed |
| Downregulated ferroptosis-related gene SQLE facilitates temozolomide chemoresistance, and invasion and affects immune regulation in glioblastoma. | CNS Neurosci Ther | 2022 | 35962621 | PubTator, text mining | PubMed |
| Recent advances of eosinophils and its correlated diseases. | Front Public Health | 2022 | 35958837 | PubTator, text mining | PubMed |
| The IFN-γ-related long non-coding RNA signature predicts prognosis and indicates immune microenvironment infiltration in uterine corpus endometrial carcinoma. | Front Oncol | 2022 | 35957871 | PubTator, text mining | PubMed |
| Phenotype Diversity of Macrophages in Osteoarthritis: Implications for Development of Macrophage Modulating Therapies. | Int J Mol Sci | 2022 | 35955514 | PubTator, text mining | PubMed |
| CD20+ T cells: an emerging T cell subset in human pathology. | Inflamm Res | 2022 | 35951029 | PubTator, text mining | PubMed |
| Targeting Serotonin With Common Antidepressants Induces Rapid Recovery From Cytopenia. | Stem Cells Transl Med | 2022 | 35946826 | PubTator, text mining | PubMed |
| A Novel Development of Sarcoidosis Following COVID-19 Vaccination and a Literature Review. | Intern Med | 2022 | 35945009 | PubTator, text mining | PubMed |
| The Tumor Immune Microenvironment and Frameshift Neoantigen Load Determine Response to PD-L1 Blockade in Extensive-Stage SCLC. | JTO Clin Res Rep | 2022 | 35941997 | PubTator, text mining | PubMed |
| Macrophages in close proximity to the vitreoretinal interface are potential biomarkers of inflammation during retinal vascular disease. | J Neuroinflammation | 2022 | 35941655 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/962/papers?page=41